Erwinia chrysanthemi asparaginase
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Erwinia chrysanthemi asparaginase, covering 2017-06-02 to 2017-06-02. Get the full timeline:
Most recent: Clinical Trial Update: Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older [Phase 1]